Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Zev D Schuman-Olivier, M.D.

Title
Institution
Department
Address
Phone
Fax

Research
The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
  1. R01CE003039 (MOORE, KATHLEEN ANNE) Sep 30, 2018 - Sep 29, 2021
    NIH
    Effects of remote motivational enhancement and MySafeRX on post-detox engagement and retention in buprenorphine treatment
    Role: Co-Principal Investigator
  2. R21AT010125 (SCHUMAN OLIVIER, ZEV DAVID) Sep 20, 2018 - Sep 19, 2019
    NIH
    Effect of Mindfulness Training on Opioid Use and Anxiety During Primary Care Buprenorphine Treatment
    Role: Principal Investigator
  3. P01AT009965 (NAPADOW, VITALY) Aug 1, 2018 - Jul 31, 2023
    NIH/NCCIH
    Boosting mind-body mechanisms and outcomes for chronic pain
    Role: Co-Investigator, Director Clinical Core
  4. R34DA040086 (SCHUMAN OLIVIER, ZEV DAVID) Apr 15, 2016 - Mar 31, 2019
    NIH
    MySafeRx: An integrated mobile platform for buprenorphine adherence
    Role: Principal Investigator
  5. UH2AT009145 (LOUCKS, ERIC) Sep 15, 2015 - Aug 31, 2020
    NIH
    Mindfulness Influences on Self-Regulation: Mental and Physical Health Implications
    Role: Co-Investigator, Site Principal Investigator

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Flores MW, Lê Cook B, Mullin B, Halperin-Goldstein G, Nathan A, Tenso K, Schuman-Olivier Z. Associations between neighborhood-level factors and opioid-related mortality: A multi-level analysis using death certificate data. Addiction. 2020 Feb 15. PMID: 32061139.
    Citations:    
  2. Wells RE, Seng EK, Edwards RR, Victorson DE, Pierce CR, Rosenberg L, Napadow V, Schuman-Olivier Z. Mindfulness in migraine: A narrative review. Expert Rev Neurother. 2020 Mar; 20(3):207-225. PMID: 31933391.
    Citations:    
  3. Sokol R, Schuman-Olivier Z, Batalden M, Sullivan L, Shaughnessy AF. A Change Management Case Study for Safe Opioid Prescribing and Opioid Use Disorder Treatment. J Am Board Fam Med. 2020 Jan-Feb; 33(1):129-137. PMID: 31907254.
    Citations:    
  4. Sokol R, Albanese M, Chew A, Early J, Grossman E, Roll D, Sawin G, Wu DJ, Schuman-Olivier Z. Building a Group-Based Opioid Treatment (GBOT) blueprint: a qualitative study delineating GBOT implementation. Addict Sci Clin Pract. 2019 12 27; 14(1):47. PMID: 31882001.
    Citations:    
  5. Sokol R, Albanese M, Albanese C, Coste G, Grossman E, Morrill D, Roll D, Sobieszczyk A, Schuman-Olivier Z. Implementing group visits for opioid use disorder: A case series. Subst Abus. 2020; 41(2):174-180. PMID: 31418638.
    Citations:    
  6. Gawande R, Pine E, Griswold T, Creedon T, Vallejo Z, Rosenbaum E, Lozada A, Schuman-Olivier Z. Insurance-Reimbursable Mindfulness for Safety-Net Primary Care Patients: A Pilot Randomized Controlled Trial. Mindfulness (N Y). 2019 Sep; 10(9):1744-1759. PMID: 32042349.
    Citations:    
  7. Steinkamp JM, Goldblatt N, Borodovsky JT, LaVertu A, Kronish IM, Marsch LA, Schuman-Olivier Z. Technological Interventions for Medication Adherence in Adult Mental Health and Substance Use Disorders: A Systematic Review. JMIR Ment Health. 2019 Mar 12; 6(3):e12493. PMID: 30860493.
    Citations:    
  8. Gawande R, To MN, Pine E, Griswold T, Creedon TB, Brunel A, Lozada A, Loucks EB, Schuman-Olivier Z. Mindfulness Training Enhances Self-Regulation and Facilitates Health Behavior Change for Primary Care Patients: a Randomized Controlled Trial. J Gen Intern Med. 2019 02; 34(2):293-302. PMID: 30511291.
    Citations:    Fields:    
  9. Schuman-Olivier Z, Borodovsky JT, Steinkamp J, Munir Q, Butler K, Greene MA, Goldblatt J, Xie HY, Marsch LA. MySafeRx: a mobile technology platform integrating motivational coaching, adherence monitoring, and electronic pill dispensing for enhancing buprenorphine/naloxone adherence during opioid use disorder treatment: a pilot study. Addict Sci Clin Pract. 2018 09 24; 13(1):21. PMID: 30249279.
    Citations:    Fields:    
  10. Khoury NM, Lutz J, Schuman-Olivier Z. Interoception in Psychiatric Disorders: A Review of Randomized, Controlled Trials with Interoception-Based Interventions. Harv Rev Psychiatry. 2018 Sep/Oct; 26(5):250-263. PMID: 30188337.
    Citations:    Fields:    
  11. Lovas DA, Schuman-Olivier Z. Mindfulness-based cognitive therapy for bipolar disorder: A systematic review. J Affect Disord. 2018 11; 240:247-261. PMID: 30086469.
    Citations:    Fields:    Translation:Humans
  12. Sokol R, LaVertu AE, Morrill D, Albanese C, Schuman-Olivier Z. Group-based treatment of opioid use disorder with buprenorphine: A systematic review. J Subst Abuse Treat. 2018 01; 84:78-87. PMID: 29195596.
    Citations:    Fields:    Translation:Humans
  13. Sokol R, Albanese C, Chaponis D, Early J, Maxted G, Morrill D, Poirier G, Puopolo F, Schuman-Olivier Z. Why use group visits for opioid use disorder treatment in primary care? A patient-centered qualitative study. Subst Abus. 2018 01 02; 39(1):52-58. PMID: 28723302.
    Citations: 1     Fields:    Translation:Humans
  14. Lovas DA, Lutz J, Schuman-Olivier Z. Meditation and Medication-What About a Middle Path? JAMA Psychiatry. 2016 12 01; 73(12):1294-1295. PMID: 27784039.
    Citations:    Fields:    
  15. Loucks EB, Schuman-Olivier Z, Britton WB, Fresco DM, Desbordes G, Brewer JA, Fulwiler C. Mindfulness and Cardiovascular Disease Risk: State of the Evidence, Plausible Mechanisms, and Theoretical Framework. Curr Cardiol Rep. 2015 Dec; 17(12):112. PMID: 26482755.
    Citations: 7     Fields:    Translation:Humans
  16. Schuman-Olivier Z, Claire Greene M, Bergman BG, Kelly JF. Is residential treatment effective for opioid use disorders? A longitudinal comparison of treatment outcomes among opioid dependent, opioid misusing, and non-opioid using emerging adults with substance use disorder. Drug Alcohol Depend. 2014 Nov 01; 144:178-85. PMID: 25267606.
    Citations: 3     Fields:    Translation:Humans
  17. Schuman-Olivier Z, Weiss RD, Hoeppner BB, Borodovsky J, Albanese MJ. Emerging adult age status predicts poor buprenorphine treatment retention. J Subst Abuse Treat. 2014 Sep; 47(3):202-12. PMID: 24953168.
    Citations: 15     Fields:    Translation:HumansPHPublic Health
  18. Schuman-Olivier Z, Hoeppner BB, Evins AE, Brewer JA. Finding the right match: mindfulness training may potentiate the therapeutic effect of nonjudgment of inner experience on smoking cessation. Subst Use Misuse. 2014 Apr; 49(5):586-94. PMID: 24611853.
    Citations: 2     Fields:    Translation:Humans
  19. Schuman-Olivier Z, Hoeppner BB, Weiss RD, Borodovsky J, Shaffer HJ, Albanese MJ. Benzodiazepine use during buprenorphine treatment for opioid dependence: clinical and safety outcomes. Drug Alcohol Depend. 2013 Oct 01; 132(3):580-6. PMID: 23688843.
    Citations: 11     Fields:    Translation:Humans
  20. Schuman-Olivier Z, Connery H, Griffin ML, Wyatt SA, Wartenberg AA, Borodovsky J, Renner JA, Weiss RD. Clinician beliefs and attitudes about buprenorphine/naloxone diversion. Am J Addict. 2013 Nov-Dec; 22(6):574-80. PMID: 24131165.
    Citations: 5     Fields:    Translation:Humans
  21. Hölzel BK, Lazar SW, Gard T, Schuman-Olivier Z, Vago DR, Ott U. How Does Mindfulness Meditation Work? Proposing Mechanisms of Action From a Conceptual and Neural Perspective. Perspect Psychol Sci. 2011 Nov; 6(6):537-59. PMID: 26168376.
    Citations: 215     Fields:    
  22. Schuman-Olivier Z, Albanese M, Nelson SE, Roland L, Puopolo F, Klinker L, Shaffer HJ. Self-treatment: illicit buprenorphine use by opioid-dependent treatment seekers. J Subst Abuse Treat. 2010 Jul; 39(1):41-50. PMID: 20434868.
    Citations: 19     Fields:    Translation:Humans
  23. Schuman-Olivier Z, Brendel DH, Forstein M, Price BH. The use of palliative sedation for existential distress: a psychiatric perspective. Harv Rev Psychiatry. 2008; 16(6):339-51. PMID: 19085388.
    Citations: 7     Fields:    Translation:Humans
  24. Margolin A, Schuman-Olivier Z, Beitel M, Arnold RM, Fulwiler CE, Avants SK. A preliminary study of spiritual self-schema (3-S(+)) therapy for reducing impulsivity in HIV-positive drug users. J Clin Psychol. 2007 Oct; 63(10):979-99. PMID: 17828761.
    Citations: 15     Fields:    Translation:Humans
  25. Beitel M, Genova M, Schuman-Olivier Z, Arnold R, Avants SK, Margolin A. Reflections by inner-city drug users on a Buddhist-based spirituality-focused therapy: a qualitative study. Am J Orthopsychiatry. 2007 Jan; 77(1):1-9. PMID: 17352579.
    Citations: 4     Fields:    Translation:Humans
  26. Beitel M, Genova M, Schuman-Olivier Z, Arnold R, Avants SK, Margolin A. . Reflections by inner-city drug users on a Buddhist-based spirituality focused therapy: A qualitative study . American Journal of Orthopsychiatry. 2007; 77(1):1-9.
  27. Hua W, Beitel M, Schuman-Olivier Z, Declan B. Psychometric properties of a Chinese version of the Psychological Mindedness Scale. J Am Psychoanal Assoc. 2007; 55(1):300-5. PMID: 17432509.
    Citations:    Fields:    Translation:Humans
  28. Margolin A, Beitel M, Schuman-Olivier Z, Avants SK. A controlled study of a spirituality-focused intervention for increasing motivation for HIV prevention among drug users. AIDS Educ Prev. 2006 Aug; 18(4):311-22. PMID: 16961448.
    Citations: 11     Fields:    Translation:Humans
  29. Schuman ZD, Abrahm JL. Implementing institutional change: an institutional case study of palliative sedation. J Palliat Med. 2005 Jun; 8(3):666-76. PMID: 15992211.
    Citations: 4     Fields:    Translation:Humans
  30. Margolin A, Schuman-Olivier Z, Avants SK. Spiritual Self Schema (3-S) Therapy DVD Training Course. 2005.
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Schuman-Olivier's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (109)
Explore
_
Co-Authors (27)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.